Patent · US Active

Anti-TIGIT antigen-binding proteins and methods of use thereof

US11453720B2 · kind B2 · utility

0Cited by

7References

21Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Nels P. Nielson · Cambridge, US
Daniel Hicklin · Montclair, US
Cynthia Seidel-Dugan · Belmont, US
William Winston · Marlborough, US
Heather Brodkin · Newton, US
Jose Andres SALMERON-GARCIA · Westminster, US
Christopher James Nirschl · Cambridge, US
Philipp Steiner · Washington, US

Key dates

Filing date	Mar 30, 2018
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Jun 8, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.